Genetically Modified Organisms and Genetic Engineering in Research and Therapy
Genetically modified organisms (GMO) raise societal, political and ethical concerns. They inspire strong resistance or, conversely, enthusiastic assent. The aim of this publication is to give an overview of genetic engineering, starting with the history of the discovery of restriction enzymes continuing with technical aspects of transgenesis to its applications in research and ethical considerations. Be it the use of single engineered cells or GMO, these applications cover a broad array, ranging from disease-oriented research (but not only), to the promising perspectives of gene therapy. Historical and technical aspects give insights into the problems inherent to the creation of GMO, and illustrate the links and limits between genetic engineering, GMOs and gene therapy. A summary article in English and French structures the links between the different chapters and concepts. Scientists interested in genetic engineering of single cells or animal models, as well as in gene therapy, will find an up-to-date review on the use and perspectives of transgenesis. However, this publication is also recommended to the public interested in the definition of GMO, which encompasses a much broader array than the genetically modified crops covered by media.
Download citation file:
Digital Version
Print Version
Table of Contents
-
1 - 32: Genetically Modified Organisms: Concepts and MethodsByPascale Piguet;Pascale PiguetaPharmazentrum, University of Basel, Basel, Switzerland;Search for other works by this author on:Philippe PoindronPhilippe PoindronbUniversité de Strasbourg, Strasbourg, FranceSearch for other works by this author on:
-
33 - 38: Restriction Enzymes: From Their Discovery to Their ApplicationsByWerner ArberWerner ArberBiozentrum, University of Basel, Basel, SwitzerlandSearch for other works by this author on:
-
39 - 49: Transforming Growth Factor-Beta Superfamily: Animal Models for Development and DiseaseByBjörn Spittau;Björn SpittauaInstitute of Anatomy and Cell Biology andSearch for other works by this author on:Eleni Roussa;Eleni RoussaaInstitute of Anatomy and Cell Biology andSearch for other works by this author on:Klaus Unsicker;Klaus UnsickeraInstitute of Anatomy and Cell Biology andSearch for other works by this author on:Kerstin KrieglsteinKerstin KrieglsteinaInstitute of Anatomy and Cell Biology andbFRIAS-Lifenet, University of Freiburg, Freiburg, GermanySearch for other works by this author on:
-
50 - 59: Transfection of Human Neuroblastoma Cells with Alzheimer’s Disease Brain Hallmarks as a Promising Strategy to Investigate the Role of Neurosteroidogenesis in NeuroprotectionByChristine Patte-Mensah;Christine Patte-MensahaEquipe Stéroïdes, Neuromodulateurs et Neuropathologies, EA-4438, Université de Strasbourg, Bâtiment 3 de la Faculté de Médecine, Strasbourg, France;Search for other works by this author on:Laurence Meyer;Laurence MeyeraEquipe Stéroïdes, Neuromodulateurs et Neuropathologies, EA-4438, Université de Strasbourg, Bâtiment 3 de la Faculté de Médecine, Strasbourg, France;Search for other works by this author on:Véronique Schaeffer;Véronique SchaefferaEquipe Stéroïdes, Neuromodulateurs et Neuropathologies, EA-4438, Université de Strasbourg, Bâtiment 3 de la Faculté de Médecine, Strasbourg, France;Search for other works by this author on:Anne Eckert;Anne EckertbNeurobiology Laboratory for Brain Aging and Mental Health, Psychiatric University Clinic, Basel, SwitzerlandSearch for other works by this author on:Ayikoe G. Mensah-NyaganAyikoe G. Mensah-NyaganaEquipe Stéroïdes, Neuromodulateurs et Neuropathologies, EA-4438, Université de Strasbourg, Bâtiment 3 de la Faculté de Médecine, Strasbourg, France;Search for other works by this author on:
-
60 - 75: Investigating Therapeutic Strategies for Fragile X Syndrome in MiceByAubin Michalon;Aubin MichalonDiscovery Neuroscience, Pharmaceuticals Division, F. Hoffmann-La Roche Ltd., Basel, SwitzerlandSearch for other works by this author on:Lothar LindemannLothar LindemannDiscovery Neuroscience, Pharmaceuticals Division, F. Hoffmann-La Roche Ltd., Basel, SwitzerlandSearch for other works by this author on:
-
76 - 85: Innovative Therapeutic Perspectives in Neuromuscular DiseasesBySusan Cure;Susan CureAssociation Française Contre les Myopathies, Evry, FranceSearch for other works by this author on:Serge BraunSerge BraunAssociation Française Contre les Myopathies, Evry, FranceSearch for other works by this author on:
-
86 - 102: Gene Therapy for Cancer Treatment – State of the ArtByAmor HajriAmor HajriInstitute of Biology III, University of Freiburg, Freiburg, GermanySearch for other works by this author on:
-
103 - 119: Manipulating the Mitochondrial Genetic SystemByAndré Dietrich;André DietrichInstitut de Biologie Moléculaire des Plantes, CNRS and Université de Strasbourg, Strasbourg, FranceSearch for other works by this author on:Daria Mileshina;Daria MileshinaInstitut de Biologie Moléculaire des Plantes, CNRS and Université de Strasbourg, Strasbourg, FranceSearch for other works by this author on:Adnan Khan Niazi;Adnan Khan NiaziInstitut de Biologie Moléculaire des Plantes, CNRS and Université de Strasbourg, Strasbourg, FranceSearch for other works by this author on:Anne Cosset;Anne CossetInstitut de Biologie Moléculaire des Plantes, CNRS and Université de Strasbourg, Strasbourg, FranceSearch for other works by this author on:Romain Val;Romain ValInstitut de Biologie Moléculaire des Plantes, CNRS and Université de Strasbourg, Strasbourg, FranceSearch for other works by this author on:Noha Ibrahim;Noha IbrahimInstitut de Biologie Moléculaire des Plantes, CNRS and Université de Strasbourg, Strasbourg, FranceSearch for other works by this author on:Frédérique Weber-LotfiFrédérique Weber-LotfiInstitut de Biologie Moléculaire des Plantes, CNRS and Université de Strasbourg, Strasbourg, FranceSearch for other works by this author on: